Radiosynoviorthesis (Radiatic Synovectomy) for Chronic Inflammatory Joint Diseases | Saarland University Hospital

The Saarland University Hospital is a leading academic medical center located in the heart of Homburg. One of its specialized treatments for chronic inflammatory joint diseases is radiosynoviorthesis (RSO), which combines elements of nuclear physics and clinical rheumatology. This procedure is conducted within the nuclear medicine department, leveraging the hospital's strong interdisciplinary network to offer a targeted alternative for patients who have not found adequate relief with systemic medication. By focusing on localized destruction of inflamed synovial tissue, the clinic aims to achieve long-term joint stability and pain reduction. The facility utilizes the advanced infrastructure of a top-tier German university center, ensuring that each procedure is supported by the latest evidence-based protocols. The procedure itself functions as a molecular precision tool, often described as a non-surgical "bloodless" synovectomy. At the UKS facility, the process involves the intra-articular injection of specific beta-emitting radionuclides, such as Yttrium-90 for larger joints like the knee or Erbium-169 for smaller finger joints, which emit localized radiation to ablate the thickened, diseased lining of the joint capsule. This targeted approach ensures that the surrounding healthy tissue remains untouched, as the radiation range is limited to mere millimeters. Clinical excellence at the hospital is further defined by a rigorous diagnostic phase that precedes every RSO application. Patients undergo a comprehensive evaluation, often including three-phase skeletal scintigraphy, to confirm active synovitis and ensure the intervention is performed only when the probability of success is high. This meticulous preparation is matched by the commitment to patient safety and radiation protection, and it adheres to the strictest European standards. The medical team ensures that the radioactive isotopes are precisely placed under sonographic or fluoroscopic guidance, reflecting the technical rigor one expects from a leading teaching hospital. Following the intervention, the protocol emphasizes a critical recovery phase characterized by brief joint immobilization. This careful post-operative management is designed to maximize isotope distribution within the joint space while preventing leakage into the lymphatic system. By integrating this specialized local therapy into a broader rheumatological care plan, Saarland University Hospital provides a bridge between conservative medical management and more invasive surgical options. The result is a highly personalized treatment journey that addresses the physical burden of chronic inflammation while maintaining the patient’s mobility and long-term quality of life.